{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T20:25:27Z","timestamp":1788121527444,"version":"build-2803163510"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Lupus nephritis (LN), one of the most common and severe complications of systemic lupus erythematosus (SLE), remains challenging to treat due to its complex pathogenesis. Hyperoside (Hyp), a naturally occurring flavonol glycoside and a key active component in numerous Chinese medicines and herbs, has demonstrated renoprotective effects via multiple signaling pathways, showing promise for LN treatment. However, its underlying mechanisms of renal protection in LN, particularly its regulatory potential on PANoptosis, remain unexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study investigated the role of PANoptosis in LN pathogenesis, focusing on protein kinase B (AKT1) -mediated podocyte PANoptosis, to elucidate the therapeutic mechanism of Hyp.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Potential Hyp targets were predicted using the SwissTargetPrediction database, while LN-related targets were retrieved from the GeneCards database. Overlapping targets were identified as potential key targets, and a Protein-Protein Interaction (PPI) network was constructed to screen core targets. GO and KEGG analyses of these overlapping targets were performed via the DAVID database to predict the mechanisms of Hyp against LN. Molecular docking between Hyp and the core target was conducted using AutoDock (Version 1.5.7) and visualized with PyMOL. Finally,\n                      <jats:italic>in vivo<\/jats:italic>\n                      and\n                      <jats:italic>in vitro<\/jats:italic>\n                      experiments, including H&amp;amp;E staining, TUNEL staining, immunofluorescence, flow cytometry, Western blotting, immunohistochemistry, and PCR, were performed to assess renal pathology, cell death, and the mRNA\/protein expression levels of key targets and PANoptosis markers.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Network pharmacology and molecular docking analyses indicated that AKT1 is a core target shared by Hyp and LN, with Hyp exhibiting stable binding to AKT1. Experimental validation demonstrated that Hyp treatment inhibited podocyte PANoptosis and alleviated renal injury in MRL\/lpr mice. Mechanistically, Hyp suppressed PANoptosis by modulating the PI3K\/AKT axis. AKT1 overexpression attenuated the therapeutic effects of Hyp, confirming its pivotal role in LN pathogenesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study reveals that AKT1-mediated podocyte PANoptosis is a key mechanism in LN and establishes Hyp as a promising therapeutic agent targeting this pathway. These findings provide a novel and clinically translatable strategy for LN treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2025.1726254","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T05:15:55Z","timestamp":1767762955000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Hyperoside ameliorates lupus nephritis by suppressing AKT1-mediated PANoptosis in podocytes: integrating network pharmacology and experimental validation"],"prefix":"10.3389","volume":"16","author":[{"given":"Lili","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongfu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanbing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"6413","DOI":"10.1038\/s41598-017-06844-2","article-title":"Hyperoside pre-treatment prevents glomerular basement membrane damage in diabetic nephropathy by inhibiting podocyte heparanase expression","volume":"7","author":"An","year":"2017","journal-title":"Sci. Rep."},{"key":"B2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/bor.0000000000000578","article-title":"The immune podocyte","volume":"31","author":"Bhargava","year":"2019","journal-title":"Curr. Opin. Rheumatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"105297","DOI":"10.1016\/j.phrs.2020.105297","article-title":"Necrostatin-1 and necroptosis inhibition: pathophysiology and therapeutic implications","volume":"163","author":"Cao","year":"2021","journal-title":"Pharmacol. Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e0184129","DOI":"10.1371\/journal.pone.0184129","article-title":"Prediction and analysis of essential genes using the enrichments of gene ontology and KEGG pathways","volume":"12","author":"Chen","year":"2017","journal-title":"PLoS One"},{"key":"B5","doi-asserted-by":"publisher","first-page":"88792","DOI":"10.18632\/oncotarget.21287","article-title":"Hyperoside alleviates adriamycin-induced podocyte injury via inhibiting mitochondrial fission","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-025-01912-1","article-title":"PANoptosis: molecular mechanisms, regulatory pathways, and implications in disease pathogenesis","author":"Chowdhury","year":"2025","journal-title":"Cell Biochem. Biophys."},{"key":"B7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.drudis.2021.09.007","article-title":"Machine-learning methods for ligand-protein molecular docking","volume":"27","author":"Crampon","year":"2022","journal-title":"Drug Discov. Today"},{"key":"B8","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules","volume":"47","author":"Daina","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s40360-025-00985-1","article-title":"Hyperoside mitigates amphotericin B-induced nephrotoxicity in HK-2 cells via bioenergetic and oxidative stress modulation","volume":"26","author":"Elmorsy","year":"2025","journal-title":"BMC Pharmacol. Toxicol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3390\/cells11050821","article-title":"miRNA-Dependent regulation of AKT1 phosphorylation","volume":"11","author":"Frederick","year":"2022","journal-title":"Cells"},{"key":"B11","doi-asserted-by":"publisher","first-page":"868343","DOI":"10.3389\/fimmu.2022.868343","article-title":"Trained immunity contribution to autoimmune and inflammatory disorders","volume":"13","author":"Funes","year":"2022","journal-title":"Front. Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1186\/s12882-025-04339-1","article-title":"Targeting panoptosis: a narrative review of its therapeutic potential in kidney disease","volume":"26","author":"Guo","year":"2025","journal-title":"BMC Nephrol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"6162","DOI":"10.3390\/ijms25116162","article-title":"Mitochondrial dysfunction in systemic lupus erythematosus with a focus on lupus nephritis","volume":"25","author":"Halfon","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","article-title":"Mechanism and regulation of NLRP3 inflammasome activation","volume":"41","author":"He","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00011-025-01994-w","article-title":"Mitochondrial dysfunction is a major cause of thromboinflammation and inflammatory cell death in critical illnesses","volume":"74","author":"Iba","year":"2025","journal-title":"Inflamm. Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e94979","DOI":"10.1172\/jci.insight.94979","article-title":"RIPK3 promotes kidney fibrosis via AKT-dependent ATP citrate lyase","volume":"3","author":"Imamura","year":"2018","journal-title":"JCI Insight"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1016\/j.ekir.2025.06.047","article-title":"Systematic review and network meta-analysis of initial treatments for lupus nephritis","volume":"10","author":"Izcovich","year":"2025","journal-title":"Kidney Int. Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"114607","DOI":"10.1016\/j.intimp.2025.114607","article-title":"Phlorizin attenuates lupus nephritis via upregulating PI3K\/Akt pathway-mediated treg differentiation","volume":"154","author":"Jiang","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"104947","DOI":"10.1016\/j.cellimm.2025.104947","article-title":"Hyperoside suppresses NSCLC progression by inducing ATG13-mediated autophagy and apoptosis","author":"Jin","year":"2025","journal-title":"Cell Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.immuni.2016.01.001","article-title":"Macrophage Akt1 kinase-mediated mitophagy modulates apoptosis resistance and pulmonary fibrosis","volume":"44","author":"Larson-Casey","year":"2016","journal-title":"Immunity"},{"key":"B21","doi-asserted-by":"publisher","first-page":"23996","DOI":"10.18632\/oncotarget.15098","article-title":"Caspase-9: structure, mechanisms and clinical application","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"B22","doi-asserted-by":"publisher","first-page":"113601","DOI":"10.1016\/j.fct.2023.113601","article-title":"Hyperoside attenuates Cd-induced kidney injury via inhibiting NLRP3 inflammasome activation and ROS\/MAPK\/NF-kappaB signaling pathway in vivo and in vitro","volume":"172","author":"Li","year":"2023","journal-title":"Food Chem. Toxicol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00011-022-01590-2","article-title":"An apoptosis inhibitor suppresses microglial and astrocytic activation after cardiac ischemia\/reperfusion injury","volume":"71","author":"Liao","year":"2022","journal-title":"Inflamm. Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"733808","DOI":"10.3389\/fimmu.2021.733808","article-title":"Hyperoside suppresses renal inflammation by regulating macrophage polarization in mice with type 2 diabetes mellitus","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10495-023-01904-7","article-title":"PANoptosis: a potential new target for programmed cell death in breast cancer treatment and prognosis","volume":"29","author":"Liu","year":"2024","journal-title":"Apoptosis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"9420073","DOI":"10.26599\/fmh.2025.9420073","article-title":"Characteristic components from rehmannia radix and their effects on insulin resistance through PI\u20103K\/AKT signaling pathway in HepG2 cells","volume":"2","author":"Liu","year":"2025","journal-title":"Food and Med. Homol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1248\/bpb.b21-01063","article-title":"PI3K\/AKT1 signaling pathway mediates sinomenine-induced hepatocellular carcinoma cells apoptosis: an in vitro and in vivo study","volume":"45","author":"Luo","year":"2022","journal-title":"Biol. Pharm. Bull."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1038\/s12276-022-00868-z","article-title":"Roles of RIPK3 in necroptosis, cell signaling, and disease","volume":"54","author":"Morgan","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"5714","DOI":"10.3390\/jcm14165714","article-title":"Autoantibodies in systemic lupus erythematosus: diagnostic and pathogenic insights","volume":"14","author":"Pagkopoulou","year":"2025","journal-title":"J. Clin. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.4049\/jimmunol.2200508","article-title":"PANoptosis: a unique innate immune inflammatory cell death modality","volume":"209","author":"Pandian","year":"2022","journal-title":"J. Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-025-00653-y","article-title":"Lupus nephritis","volume":"11","author":"Parodis","year":"2025","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B32","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/ijms21010131","article-title":"Hyperoside induces breast cancer cells apoptosis via ROS-mediated NF-\u03baB signaling pathway","volume":"21","author":"Qiu","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41580-023-00649-0","article-title":"FOXO transcription factors as mediators of stress adaptation","volume":"25","author":"Rodriguez-Colman","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.2147\/JIR.S403819","article-title":"PANoptosis: a cell death characterized by pyroptosis, apoptosis, and necroptosis","volume":"16","author":"Shi","year":"2023","journal-title":"J. Inflamm. Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.3390\/cells11233834","article-title":"Delivery of active AKT1 to human cells","volume":"11","author":"Siddika","year":"2022","journal-title":"Cells"},{"key":"B36","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/iub.2826","article-title":"Delivery of AKT1 phospho-forms to human cells reveals differential substrate selectivity","volume":"76","author":"Siddika","year":"2024","journal-title":"IUBMB Life"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1.30.31","DOI":"10.1002\/cpbi.5","article-title":"The GeneCards suite: from gene data mining to disease genome sequence analyses","volume":"54","author":"Stelzer","year":"2016","journal-title":"Curr. Protoc. Bioinforma."},{"key":"B38","doi-asserted-by":"publisher","first-page":"D609","DOI":"10.1093\/nar\/gkae1010","article-title":"UniProt: the universal protein knowledgebase in 2025","volume":"53","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1080\/08916934.2017.1402302","article-title":"The relationship between cell apoptosis dysfunction and FEN1 E160D mutation in lupus nephritis patients","volume":"50","author":"Wang","year":"2017","journal-title":"Autoimmunity"},{"key":"B40","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.2147\/jir.S418222","article-title":"Potential implications of hyperoside on oxidative stress-induced human diseases: a comprehensive review","volume":"16","author":"Wang","year":"2023","journal-title":"J. Inflamm. Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"156996","DOI":"10.1016\/j.phymed.2025.156996","article-title":"Total glucosides of paeony ameliorates lupus nephritis by suppressing ZBP1-mediated PANoptosis in podocytes","volume":"145","author":"Wang","year":"2025","journal-title":"Phytomedicine"},{"key":"B42","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nri3901","article-title":"Regulation of innate immune cell function by mTOR","volume":"15","author":"Weichhart","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/jdi.13660","article-title":"VX-765 ameliorates renal injury and fibrosis in diabetes by regulating caspase-1-mediated pyroptosis and inflammation","volume":"13","author":"Wen","year":"2022","journal-title":"J. Diabetes Investig."},{"key":"B44","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1080\/10715762.2019.1623883","article-title":"Protective effect of hyperoside against renal ischemia-reperfusion injury via modulating mitochondrial fission, oxidative stress, and apoptosis","volume":"53","author":"Wu","year":"2019","journal-title":"Free Radic. Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41392-025-02253-4","article-title":"Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduct. Target Ther."},{"key":"B46","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1080\/00498254.2023.2270046","article-title":"Hyperoside ameliorates cisplatin-induced acute kidney injury by regulating the expression and function of Oat1","volume":"53","author":"Yuan","year":"2023","journal-title":"Xenobiotica"},{"key":"B47","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1007\/s11418-016-1007-z","article-title":"Hyperoside reduces albuminuria in diabetic nephropathy at the early stage through ameliorating renal damage and podocyte injury","volume":"70","author":"Zhang","year":"2016","journal-title":"J. Nat. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"5871","DOI":"10.1002\/ptr.7993","article-title":"Hyperoside mediates protection from diabetes kidney disease by regulating ROS-ERK signaling pathway and pyroptosis","volume":"37","author":"Zhang","year":"2023","journal-title":"Phytother. Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1538601","DOI":"10.3389\/fphar.2025.1538601","article-title":"The multiple biological activities of hyperoside: from molecular mechanisms to therapeutic perspectives in neoplastic and non-neoplastic diseases","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41392-022-01219-0","article-title":"Intestinal dysbiosis exacerbates the pathogenesis of psoriasis-like phenotype through changes in fatty acid metabolism","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1136\/ard-2023-224242","article-title":"SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy","volume":"82","author":"Zhao","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jphs.2021.02.005","article-title":"Hyperoside ameliorates diabetic nephropathy induced by STZ via targeting the miR-499-5p\/APC axis","volume":"146","author":"Zhou","year":"2021","journal-title":"J. Pharmacol. Sci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1120034","DOI":"10.3389\/fimmu.2023.1120034","article-title":"Advances in mechanism and regulation of PANoptosis: prospects in disease treatment","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Immunol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1726254\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T05:15:59Z","timestamp":1767762959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1726254\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":53,"alternative-id":["10.3389\/fphar.2025.1726254"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1726254","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"article-number":"1726254"}}